What is Mounjaro?
Mounjaro is a prescription medication used to improve blood sugar control in adults with type 2 diabetes [1]. It is administered through injection [1].
What is the wholesale price of Mounjaro?
The wholesale acquisition cost (WAC) for Mounjaro varies by dosage. As of January 2024, the WAC for Mounjaro 5 mg/0.5 mL, 10 mg/0.5 mL, and 15 mg/0.5 mL injection is $972.91 per carton [2]. Each carton contains four single-dose pens [2].
When did Mounjaro receive FDA approval?
Mounjaro received FDA approval in May 2022 [1].
What is Mounjaro used to treat?
Mounjaro is indicated to improve glycemic control in adults with type 2 diabetes mellitus [1].
What are the active ingredients in Mounjaro?
Mounjaro contains tirzepatide [1]. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [1].
Who manufactures Mounjaro?
Mounjaro is manufactured by Eli Lilly and Company [1].
How does Mounjaro work?
Tirzepatide is a dual agonist that activates the GLP-1 and GIP receptors [1]. This dual action helps to improve blood sugar levels by increasing insulin secretion, reducing glucagon secretion, delaying gastric emptying, and improving insulin sensitivity [1].
How is Mounjaro administered?
Mounjaro is administered as a subcutaneous injection [1].
What are the available dosages of Mounjaro?
Mounjaro is available in multiple dosage strengths, including 5 mg/0.5 mL, 10 mg/0.5 mL, and 15 mg/0.5 mL [2].
What is the difference between Mounjaro and other diabetes medications?
Mounjaro's mechanism of action is distinct as it targets both GIP and GLP-1 receptors, unlike many other diabetes medications that target only one of these pathways [1]. This dual action may offer enhanced glycemic control [1].
What are the potential side effects of Mounjaro?
Common side effects of Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, and abdominal pain [1]. Serious side effects can also occur [1].
What is the patent status of Mounjaro?
Information regarding the patent status of Mounjaro and its active ingredient, tirzepatide, can be found on DrugPatentWatch.com [3]. Patents play a crucial role in the exclusivity period of a drug [3].
When does Mounjaro's patent expire?
Specific patent expiry dates for Mounjaro are typically available through specialized patent databases and information services. DrugPatentWatch.com provides detailed patent information for pharmaceuticals, which would include Mounjaro [3].
Can generic versions of Mounjaro be developed?
The development of generic or biosimilar versions of Mounjaro is contingent upon the expiration of relevant patents and regulatory approvals. The timeline for such developments is closely linked to the patent landscape [3].
What is the wholesale acquisition cost (WAC) for Mounjaro?
The WAC for Mounjaro is $972.91 per carton for the 5 mg, 10 mg, and 15 mg dosage strengths, with each carton containing four single-dose pens [2].
How does Mounjaro's price compare to other diabetes treatments?
Pricing comparisons for Mounjaro against other diabetes treatments would depend on the specific drug, dosage, and the patient's insurance coverage or discount programs. Wholesale acquisition cost represents the manufacturer's list price before any discounts or rebates.
---
Sources:
[1] Mounjaro Prescribing Information: https://www.mounjaro.com/
[2] Drug Information Association (DIA) Catalog, January 2024 Data: https://www.druginformation.com/
[3] DrugPatentWatch.com: https://www.drugpatentwatch.com/